Novra Technologies converted $3.2 million of its convertible debt into 12.8 million common shares issued to SNAPS Holding Company, making SNAPS a 29.5% shareholder and an insider. The previously announced $5.3 million convertible loan agreement with SNAPS expired without any funds received, leading Novra to consider SNAPS in default. All loan principal was converted to equity and accrued interest forgiven. Novra expects SNAPS to propose a solution for the default but is not currently negotiating financing. A trading blackout on Novra's directors and officers will end on October 13, 2026.
Novra Technologies' loan update is presented here alongside Pluang's Technology sector snapshot. As of Oct 07, 2026 04:05 WIB, out of 150 priced Technology stocks, 89 rose and 60 fell. Notably, Remitly Global Inc (RELY) rose 5.83% with 100% buy orders and a typical hold time of 53 days, contrasting with Marvell Technology Inc (MRVL) which rose 5.76% but had 62% sell orders and a shorter hold time of 42 days.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
